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ABSTRACT 
Schmidt H, Stuertz K, Chen V, Stringaris AK, BrOck W, Nau R. Glycerol does not reduce neuronal 
damage in experimental Streptococcus pneumoniae meningitis, lnflammopharmacology. 1998;6:19 26. 
To study the effect ofhigh-dose glycerol therapy on inflammation and neuronal destruction in a model 
of experimental pneumococcal meningitis, 14 New Zealand White rabbits were infected intracisternally 
with Streptococcus pneumoniae type 3. Sixteen hours after infection, 7 animals received intravenous 
glycerol therapy (1 gkg t bolus and 0.5 gkg i h 1 maintenance dose) and 7 animals served as unt eated 
controls. 
After 8 h of therapy, the glycerol CSF:serum ratio exceeded the previously observed alues in 
rabbits with an intact blood CSF barrier (0.72_+0.25 vs. 0.35), i.e. glycerol crossed th  blood-CSF 
barrier more readily in animals altered by meningitis than n heallhy animals. In contrast, he brain 
tissue:sermn ratio of glycerol (grey matter 0.33 _+ 0.29, white matter 0.30 + 0.31) was substantially ower 
than the CSF:serum ratio @=0.03 and p=0.047). There was no significant effect of glycerol on 
intracranial pressure, brain water content and neuron-specific enolase release into the CSF. Glycerol 
significantly increased the density of neuronal apoptosis in the dentate gyrus of the hippocampal 
formation. Therefore, glycerol does not appear to be beneficial in experimental pneumococcal 
meningitis. 
Keyn,ordw apoptosis, glycerol, meningitis, neuron-specific enolase, Str ptococcus pneumoniae 
INTRODUCTION 
For more than 30 years, hyperosmolar glycerol solution has been applied to treat 
cerebral oedema and intracranial pressure in cerebral ischaemia [1]. Several studies 
reported positive effects on survival and neurological sequelae in patients with cerebral 
ischaemia [2 4]. Not only ischaemia but also inflammatory cerebral diseases induce 
cerebral oedema and increase intracranial pressure complicating the course of the 
disease. In addition to the dehydrating effect on brain tissue, a direct cerebroprotective 
action has been ascribed to glycerol. The rapid distribution of glycerol within the brain 
[5] may cause a decreased cellular loss of free fatty acids and inorganic phosphate in 
damaged areas and a rise of the rate of glucose and oxygen consumption [6]. Glycerol 
preserves the cerebral ultrastructure in experimental ischaemia fter middle cerebral 
artery occlusion in the squirrel [7]. It has antioxidative properties and may activate the 
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serum prostaglandin PGI2 [8] which in turn induces an increase of cerebral blood flow 
by vasodilation. With moderate hyperosmolarity, in healthy rats glycerol causes 
increased taurine, aspartic a id, alanine, leucine and lysine levels in brain tissue [9] 
and may thereby act as a cerebroprotective agent. Kilpi et al. [10] treated children with 
bacterial meningitis w th an oral glycerol regimen (4.5 g kg-I d ~ po) or dexamethasone 
(1.5 mgkg ~ d I iv) or both as an adjunct o antibiotic treatment. The end points of this 
study were persisting neurological bnormalities and impairment of hearing. Glycerol- 
treated children, with or without additional dexamethasone th rapy, had significantly 
fewer neurological abnormalities and hearing impairments han those receiving only 
antibiotic treatment or adjunctive treatment with dexamethasone. 
This study prompted us to evaluate the role of glycerol as an adjunctive agent in 
Streptococcus pneumoniae meningitis with respect o parameters of inflammation and 
neuronal destruction. We also studied the entry of glycerol into CSF and brain tissue in
the presence of meningeal inflammation. 
MATERIALS AND METHODS 
Test organism 
A Streptococcus pneumoniae type 3 strain originally isolated from an adult with 
meningitis (gift of M.G. Tfiuber MD, Division of Infectious Diseases, University of 
California, San Francisco) was used as an inoculum. Its ability to cause meningeal 
inflammation has been characterized previously [11]. 
Drugs 
Glycerol was infused as a 10% solution in a NaCI (0.45%)/Glucose (0.275%) solution 
(Glycerosteril 10%, Fresenius, Bad Homburg, Germany). 
Rabbit model 
After induction of anaesthesia with intramuscular ketamine (Ketavet, Parke-Davis, 
Berlin, Germany; 25mg/kg) and xylazine (Rompun, Bayer, Leverkusen, Germany; 5 
mg/kg), New Zealand White rabbits (approximately 2.5 kg) were anaesthetized by
intravenous urethane (Sigma Chemicals, Taufkirchen, Germany) for the entire experi- 
ment (24 h). Blood was drawn from the contralateral ear artery. A lumbar puncture 
needle (22G x 3.5 inches; Spinocan, Braun, Melsungen, Germany) was used as an 
intracisternat dwelling catheter and was connected to a pressure transducer (Gould 
Statham R23 ID) for measurement of intracerebral pressure (ICP). Data on ICP was 
stored by a computerized intensive care monitor (Servomed, SMC 108 monitoring 
device, Hellige, Freiburg, Germany). 
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Meningitis was induced by intracisternal injection of l06 CFU Streptococcus pneu- 
moniae type 3. Until the start of glycerol treatment, both groups received 5 ml kg i h 1 
of 0.9% saline. At 16 h later, 7 rabbits received a a bolus injection of 1 g/kg glycerol 
(= 10 ml/kg) followed by a continous glycerol infusion of 0.5 g kg 1 h--1 (=5 ml kg-1 h-i). 
Seven control animals received the same volume of NaCI (0.9%). Blood (3 ml) and 
CSF (0.3 ml) were drawn before and at 6 h, 12 h, 18 h and 24 h after infection. 
Sample processing 
After coagulation, blood was centrifuged at 3000g for 5 min and the supernatant was 
immediately frozen at 80°C. CSF white blood cells were counted in a Fuchs 
Rosenthal haemocytometer. Pneumococcal CSF titres were determined by plating 10 
pl of serial ten-fold dilutions on blood agar plates, which were then incubated 
overnight at 37'~C with 5% CO2. Bacterial titres at 6, 12, 18 and 24 h served for 
determination of log-linear regression analysis (NogCFU ml ~h 1). The remaining 
CSF was immediately centrifuged at 3000g for 5 min and the supernatants were stored 
at 80°C. 
At 24 h after infection, the rabbits were sacrificed by iv injection of 75 mg thiopental. 
Thereafter, the skull was opened and the brain was carefully removed and dissected. 
One half was immediately weighed and dried for 10 d to constant weight in an oven at 
120°C. The brain water content was calculated as grams (g) of water per g of dry 
weight. The frontal part was dissected away from the remaining cerebral hemisphere to
prepare grey and white matter for the measurement of glycerol concentrations. The 
posterior part containing the hippocampus was fixed in paraformaldehyde and 
embedded in paraffin blocks. 
Determination of glycerol concentrations 
After weighing, brain tissue was mechanically homogenized in a glass potter. The 
specimen was cooled by ice water and exposed for 10 rain to a Sonifier Cell Disruptor 
ultrasound evice (Branson Sonic Power, Danbury, CT, USA). After a heating period 
of 30 rain in a 55'~C water bath, glycerol was measured enzymatically in the 
homogenized brain tissue, CSF and serum (test kit No. 148270, Boehringer Man- 
nheim, Germany) [12]. 
Quant(fication of neuronal damage 
NSE concentrations in CSF were measured with an immunoluminometric assay (LIA- 
mat NSE Prolifigen, Byk-Sangtec, Dietzenbach, Germany). CSF lactate concentra- 
tions were quantified enzymatically (Biosen, Dreieich, Germany), CSF protein content 
by nephelometry. 
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The density of apoptotic neurons in the gyrus dentatus of the hippocampus after 24 h 
of meningitis was visualized by in situ tailing [13], quantitated by planimetry (Contron 
Videoplan, Grundig, Ntirnberg, Germany) and expressed as the number of labelled 
neurons per mm 2 of hippocampal granular cell layer [14]. 
Statistics 
Data were expressed as means + standard eviation (SD). Unpaired two-tailed t-test 
was used for comparison; p < 0.05 was considered statistically significant. 
RESULTS 
Glycerol kinetics 
Glycerol readily crossed the inflamed blood CSF barrier. The mean_+SD CSF 
concentration was 2.25+1.15 g/L in normal animals compared with a serum 
concentration of 3.53__+0.68 g/L 24 h after infection. This resulted in a CSF:serum 
ratio of 0.72+0.25. Concentrations of glycerol in the CSF were significantly higher 
than in the white matter (2.25 _+ 1.15 g/L vs. 0.91 _+0.67 g/L, p = 0.032) and in the grey 
matter (2.25_+ 1.15 g/L vs. 1.02_+0.70, p=0.029). (Figure 1). The mean_+STD, the 
white matter:serum glycerol ratio (0.30+_0.31) and the grey matter:serum glycerol 
ratio (0.33_+0.29) were similar to those found by Waterhouse and Coxon [15] in 
healthy rabbits 7 h after continuous glycerol infusion (mean = 0.42). 
Measurement of ICP 
The mean ICP decreased in the first 3 h of treatment after initiation of therapy 16 h 
after infection, in the glycerol-treated group (differences vs. controls not significant; 
Table 1). 
Parameters of" CNS inflammation 
The course of the CSF leucocyte count, the bacterial density, and concentration of 
lactate in the CSF were nearly identical in glycerol-treated and control animals (Table 
1). The protein concentrations in the CSF as a parameter of b loo~CSF barrier 
damage were not significantly different (Table 1). 
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Figure 1. Changes in mean _+ SD of glycerol in CSF, serum and brain tissue 24 h after infection 
Determination of brain oedema 
The mean brain water content in treated animals was lower than that in control rabbits 
(3.87 +0.65 vs. 4.46___ 0.38 gwater per gdry weight) CO = 0.07). 
Parameters of neuronal destruction 
The concentration of neuron-specific enolase in CSF was not significantly different 
between glycerol-treated and control animals (mean+SD 31.8+25.0 ng/ml vs. 
107.8 + 139.5 ng/ml, p = 0.17). The mean density of apoptotic neurons in the dentate 
gyrus was significantly higher in the glycerol-treated than in the untreated group 
(p = 0.0014; Table 1). 
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TABLE 1 
Effects of glycerol treatment on parameters of meningococcal infection in rabbits 
Glycerol-treated Control group 
Parameter animals (mean_+ SD) (mean _+ SD) 
CSF leucocyte density (n/gl) 
12 h post-infection 
18 h post-infection 
24 h post-infection 
1463 ± 3106 1635 ±3515 
10239_+ 14380 20751 _+29249 
23800 ± 34100 28102 ± 27592 
Log CFU/ml 
12 h post-infection 7.9_+ 1.1 7.0_+ 0.6 
18 h post-infection 9.0_+0.8 8.4_+0.8 
24 h post-infection 9.1 _+0.6 8.4_+0.6 
6log CFUml 1 h i 0.17±0.06 0.15_+0.06 
ICP (mmHg) 
16 h post-infection 5.5 _+ 5.1 5.0 _+ 8.3 
18 h post-infection 4.0 _+ 7.1 2.6 _+ 8.4 
21 h post-infection 4.1 _+ 10.6 9.2_+4.8 
24 h post-infection 3.3 _+ 10.7 6.3 +_ 8.3 
CSF lactate (mmol/L) 
12 h post-infection 3.2 ± 2.1 7.8 _+ 5.4 
18 h post-infection 8.1 _+ 3.6 9.6 _+ 6.0 
24 h post-infection 13.5 _+ 9.6 12.9 +_ 6.45 
CSF protein content (mg/L) 
6 h post-infection 
24 h post-infection 
Density of apoptotic neurons in the 
dentate gyrus (ram 2) 
1613.2_+ 824.8 
4232.0_+ 1223.1 
1580.8_+ 1514,5 
3682.7+2701.5 
244.3 ± 57.1 ** 130.5±45.9"* 
1CP, intracisternal pressure; CSF~ cerebrospinal fluid; CFU, colony-forming unit 
D ISCUSSION 
The introduction of  antibiotic therapy has decreased the mortality of  pneumococcal 
meningitis from 100% to 20-30%. Nevertheless, in surviving patients, neurological 
sequelae are frequent. Up to 50% of the survivors suffer from cognitive dysfunction, 
seizures, hearing impairment or focal neurological abnormalities. These effects are 
caused partly by the bacteria themselves but also by a sudden activation of the 
inf lammatory cascade induced by bacterial cell wall products, peaking after the 
initiation of the treatment with cytolytic antibiotics (e.g. [3-1actam). 
Glycerol in Experimental Meningitis 25 
Various efforts have been made to attenuate the inflammatory response of the 
immune system in early meningitis. The beneficial effect of dexamethasone adminis- 
tration before the start of antibiotic therapy for bacterial meningitis in children of two 
months or older has been documented in a randomized study [16] and is recommended 
by several authorities (e.g. the American Academy of Pediatrics [17]). However, 
dexamethasone treatment of bacterial meningitis increased apoptotic neuronal da- 
mage in the dentate gyrus of the hippocampal formation [14]. Moreover, dexametha- 
sone decreases the passage of antibiotics from blood to CSF [18]. Cleavage products of 
gram-positive bacteria are able to increase intracerebral pressure and brain oedema 
[191. Yet, antibiotics acting bactericidally, not by cell wall ysis, such as rifamycins and 
quinolones delayed the inflammatory response; they did not reduce neuronal damage 
in experimental pneumococcal meningitis [20, 21]. 
Studies examining the reduction of brain oedema in meningitis by therapy with osmotic 
agents are rare. Syrogiannopoulos et al. [22] administered mannitol in a Haemophilus 
influenzae type b meningitis rabbit model and were able to reduce lactate and hypox- 
anthine concentrations in the CSF of mannitol-treated animals. The Finnish glycerol 
study [10] claimed asignificantly ower percentage ofhearing loss and other neurological 
abnormalities in antibiotic-treated children with bacterial meningitis receiving lycerol 
alone or plus dexamethasone as adjuvants versus no adjunctive treatment or dexametha- 
sone. The design of this study, however, was inadequate. Thus 30 patients received glycerol 
alone (group 1) and 34 dexamethasone plus glycerol (group 2). A total of 32 children 
received examethasone alone (group 3) and 26 had no adjunctive treatment (group 4). A 
comparison of all four groups did not yield significant differences; groups 1 and 2, and 
groups 3 and 4 were combined, and compared with each other. Furthermore, no 
adjustment ofthe s-error was performed to account for repeated testing. 
The objective of our study was to evaluate the effect of glycerol on brain oedema nd 
neuronal damage in pneumococcal meningitis. To minimize interfering variables, 
infected animals were not treated with an antibiotic agent. Glycerol entered the CSF 
more readily in infected animals than in healthy animals as previously reported by 
Waterhouse and Coxon [15]. In contrast, glycerol brain tissue:serum ratios in animals 
suffering from meningitis were almost equal to those in non-meningitic animals [15]. 
This implies that (a) despite a pronounced isturbance of the blood CSF barrier the 
blood brain barrier appears less affected in early bacterial meningitis, and (b) the long 
diffusional distances and the bulk flow of the interstitial fluid of the brain tissue 
towards the subarachnoid space prevents equilibration between brain tissue and CSF. 
As in Haemophilus influenzae type b meningitis [22], the osmotic treatment resulted 
in a decrease in mean brain water content and in a slight reduction of intracranial 
pressure. However, in our study, the differences were not significant. The CSF 
concentrations of lactate, however, were not affected by the glycerol treatment. 
In conclusion, glycerol readily entered the cerebrospinal f uid in experimental 
meningitis. Its concentrations were substantially lower in brain tissue than in CSF. 
Glycerol did not reduce parameters of neuronal damage. The design and statistical 
evaluation of the only study conducted in children claiming a beneficial effect of 
glycerol as an adjunct in bacterial meningitis is not convincing. For these reasons, at 
present, there is no indication for routine use of glycerol in bacterial meningitis. 
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